AUA2022: Incorporating Genomic Testing For Prostate Cancer Into Your Practice

Incorporating Genomic Testing for Prostate Cancer into Your Practice (2022) CME Available: https://auau.auanet.org/node/36074 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss the research studies that led to the approval of genomic testing for prostate cancer 2. Order appropriate genomic testing based on a patient's unique clinical situation 3. State the NCCN and AUA guidelines for genomic testing for prostate cancer 4. Discern the different prognostic clinical endpoints provided by various genomic tests 5. Recognize candidates for, and implications of, germline testing for prostate cancer